This is a Validated Antibody Database (VAD) review about rat Bcl2l1, based on 201 published articles (read how Labome selects the articles), using Bcl2l1 antibody in all methods. It is aimed to help Labome visitors find the most suited Bcl2l1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Bcl2l1 synonym: Bcl-xl; Bcl2l; Bclx; bcl-X

Knockout validation
Cell Signaling Technology
domestic rabbit monoclonal (54H6)
  • western blot knockout validation; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Bcl2l1 antibody (CST, 2764) was used in western blot knockout validation on human samples at 1:1000 (fig 3a). Proc Natl Acad Sci U S A (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C78F1)
  • immunoprecipitation; human; loading ...; fig 5f
  • western blot; human; loading ...; fig 5f
  • western blot knockout validation; mouse; loading ...; fig 6c
  • immunoprecipitation; mouse; loading ...; fig 5a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 4237) was used in immunoprecipitation on human samples (fig 5f), in western blot on human samples (fig 5f), in western blot knockout validation on mouse samples (fig 6c) and in immunoprecipitation on mouse samples (fig 5a). Signal Transduct Target Ther (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C78F1)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig s1c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, C78F1) was used in western blot knockout validation on mouse samples at 1:1000 (fig s1c). Nat Commun (2019) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (54H6)
  • immunohistochemistry knockout validation; mouse; fig 1
  • western blot knockout validation; mouse; fig 1
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in immunohistochemistry knockout validation on mouse samples (fig 1) and in western blot knockout validation on mouse samples (fig 1). Mol Cell Neurosci (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (H-5)
  • western blot; human; loading ...; fig 1g
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc8392) was used in western blot on human samples (fig 1g). Front Oncol (2022) ncbi
mouse monoclonal (H-5)
  • western blot; human; 1:1000; loading ...; fig 6e
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples at 1:1000 (fig 6e). Front Oncol (2021) ncbi
mouse monoclonal (H-5)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples (fig 4a). Front Immunol (2021) ncbi
mouse monoclonal (H-5)
  • western blot; human; 1:500; loading ...; fig 2d
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotechnology, sc-8392) was used in western blot on human samples at 1:500 (fig 2d). Cancers (Basel) (2021) ncbi
mouse monoclonal (7B2.5)
  • western blot; human; fig 1b
Santa Cruz Biotechnology Bcl2l1 antibody (Santa, 7B2.5) was used in western blot on human samples (fig 1b). Oncogenesis (2020) ncbi
mouse monoclonal (H-5)
  • western blot; human; fig 2k
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples (fig 2k). Oncogene (2020) ncbi
mouse monoclonal (H-5)
  • western blot; human; loading ...; fig 4f
Santa Cruz Biotechnology Bcl2l1 antibody (Santa, sc-8392) was used in western blot on human samples (fig 4f). J Clin Invest (2019) ncbi
mouse monoclonal (H-5)
  • western blot; human; 1:1000; loading ...; fig 5a
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples at 1:1000 (fig 5a). J Biol Chem (2018) ncbi
mouse monoclonal (7B2.5)
  • western blot; human; 1:100; loading ...; fig 4f
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotechnology, Inc, SC56021) was used in western blot on human samples at 1:100 (fig 4f). Mol Med Rep (2018) ncbi
mouse monoclonal (H-5)
  • flow cytometry; mouse; loading ...; fig s4b
Santa Cruz Biotechnology Bcl2l1 antibody (Santa, H-5) was used in flow cytometry on mouse samples (fig s4b). Front Immunol (2018) ncbi
mouse monoclonal (H-5)
  • western blot; mouse; loading ...; fig 5b
Santa Cruz Biotechnology Bcl2l1 antibody (SantaCruz, sc-8392) was used in western blot on mouse samples (fig 5b). J Clin Invest (2017) ncbi
mouse monoclonal (H-5)
  • flow cytometry; human; loading ...; fig 1d
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, H-5) was used in flow cytometry on human samples (fig 1d). Cell Signal (2017) ncbi
mouse monoclonal (2H12)
  • western blot; human; 1:250; fig 4
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-23958) was used in western blot on human samples at 1:250 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (H-5)
  • western blot; human; loading ...; fig 3e
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples (fig 3e). Cell Death Discov (2016) ncbi
mouse monoclonal (H-5)
  • western blot; human; 1:1000; loading ...; fig 1g
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples at 1:1000 (fig 1g). Mol Med Rep (2016) ncbi
mouse monoclonal (H-5)
  • western blot; human; fig 5e
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples (fig 5e). Oncotarget (2016) ncbi
mouse monoclonal (4H33)
  • flow cytometry; human; 1:50; fig 4a
In order to assess the effect of shepherdin, a peptido-mimetic that inhibits the heat shock protein-Survivin interaction, in retinoblastoma, Santa Cruz Biotechnology Bcl2l1 antibody (Santacruz, sc-70418) was used in flow cytometry on human samples at 1:50 (fig 4a). Chem Biol Interact (2016) ncbi
mouse monoclonal (H-5)
  • western blot; human; fig s6
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples (fig s6). Genes Dev (2016) ncbi
mouse monoclonal (H-5)
  • western blot; human; 1:1000; loading ...; fig 3a
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc8392) was used in western blot on human samples at 1:1000 (fig 3a). FEBS Lett (2016) ncbi
mouse monoclonal (H-5)
  • flow cytometry; mouse; loading ...; fig 5d
  • western blot; mouse
In order to identify a role for Sca-1 in mouse gastric cancer, Santa Cruz Biotechnology Bcl2l1 antibody (santa cruz, sc-8392) was used in flow cytometry on mouse samples (fig 5d) and in western blot on mouse samples . Stem Cells (2016) ncbi
mouse monoclonal (H-5)
  • western blot; rat; fig 5f
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on rat samples (fig 5f). Apoptosis (2016) ncbi
mouse monoclonal (H-5)
  • immunohistochemistry - frozen section; rat; 1:200; fig 1
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in immunohistochemistry - frozen section on rat samples at 1:200 (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (H-5)
  • western blot; human; loading ...; fig 2d
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, 8392) was used in western blot on human samples (fig 2d). Sci Adv (2015) ncbi
mouse monoclonal (2H12)
  • western blot; human; 1:1000; fig 4
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-23958) was used in western blot on human samples at 1:1000 (fig 4). Endocr Relat Cancer (2016) ncbi
mouse monoclonal (2H12)
  • western blot; human; 1:500; fig 7
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-23958) was used in western blot on human samples at 1:500 (fig 7). PLoS ONE (2015) ncbi
mouse monoclonal (H-5)
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotechnology, sc-8392) was used in western blot on human samples (fig 4b). Cancer Cell Int (2015) ncbi
mouse monoclonal (H-5)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 3
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, H-5) was used in immunohistochemistry - paraffin section on human samples (tbl 3). PLoS ONE (2015) ncbi
mouse monoclonal (H-5)
  • western blot; human; loading ...; fig st2
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples (fig st2). Oncotarget (2015) ncbi
mouse monoclonal (H-5)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:20; fig 3
Santa Cruz Biotechnology Bcl2l1 antibody (santa Cruz, sc-8392) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:20 (fig 3). Oxid Med Cell Longev (2015) ncbi
mouse monoclonal (H-5)
  • western blot; human; fig 4
Santa Cruz Biotechnology Bcl2l1 antibody (santa Cruz, sc8392) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (H-5)
  • western blot; human; fig 4
Santa Cruz Biotechnology Bcl2l1 antibody (santa Cruz, sc-8392) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (H-5)
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotechnology, sc-8392) was used in western blot on human samples (fig 2a). Oncotarget (2015) ncbi
mouse monoclonal (H-5)
  • western blot; mouse; loading ...; fig 7d
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, 8392) was used in western blot on mouse samples (fig 7d). Oncotarget (2015) ncbi
mouse monoclonal (H-5)
  • western blot; rat
  • immunocytochemistry; human
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, SC-8392) was used in western blot on rat samples and in immunocytochemistry on human samples . Toxicol Lett (2015) ncbi
mouse monoclonal (H-5)
  • western blot; rat; loading ...; fig 6b
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotechnology, sc-8392) was used in western blot on rat samples (fig 6b). PLoS ONE (2015) ncbi
mouse monoclonal (H-5)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2a
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2a). Oncotarget (2015) ncbi
mouse monoclonal (44)
  • western blot; human; 1:100; fig 3
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-136207) was used in western blot on human samples at 1:100 (fig 3). Oncol Lett (2015) ncbi
mouse monoclonal (H-5)
  • western blot; mouse; 1:1000; loading ...; fig 5A
Santa Cruz Biotechnology Bcl2l1 antibody (Cell Signaling, sc-8392) was used in western blot on mouse samples at 1:1000 (fig 5A). Physiol Rep (2015) ncbi
mouse monoclonal (H-5)
  • western blot; human
In order to identify binding partners ANKHD1 in leukemia cells, Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotechnology, sc-8392) was used in western blot on human samples . Biochim Biophys Acta (2015) ncbi
mouse monoclonal (H-5)
  • western blot; human
In order to study the effect of Imatinib on VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells, Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotechnology, sc-8392) was used in western blot on human samples . Biochim Biophys Acta (2015) ncbi
mouse monoclonal (H-5)
  • western blot; human; 1:2000
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in western blot on human samples at 1:2000. Cell Death Dis (2014) ncbi
mouse monoclonal (H-5)
  • immunohistochemistry - paraffin section; human; fig 5
  • western blot; human; 1:500; fig 5
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, sc-8392) was used in immunohistochemistry - paraffin section on human samples (fig 5) and in western blot on human samples at 1:500 (fig 5). Oncol Rep (2014) ncbi
mouse monoclonal (H-5)
  • western blot; human
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz biotechnology, sc-8392) was used in western blot on human samples . Int J Biol Macromol (2015) ncbi
mouse monoclonal (H-5)
  • flow cytometry; human
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz, H5) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (H-5)
  • western blot; human
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotech, sc-8392) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (H-5)
  • western blot; human; 1:100
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotechnology, sc-8392) was used in western blot on human samples at 1:100. Biomed Res Int (2014) ncbi
mouse monoclonal (H-5)
  • immunoprecipitation; mouse
  • western blot; mouse
Santa Cruz Biotechnology Bcl2l1 antibody (Santa Cruz Biotechnology, sc-8392) was used in immunoprecipitation on mouse samples and in western blot on mouse samples . PLoS ONE (2014) ncbi
Abcam
domestic rabbit monoclonal (EPR16642)
  • immunohistochemistry; mouse; 1:4000; loading ...; fig 8g
Abcam Bcl2l1 antibody (Abcam, ab178844) was used in immunohistochemistry on mouse samples at 1:4000 (fig 8g). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (E18)
  • western blot; human; loading ...; fig 5a
Abcam Bcl2l1 antibody (Abcam, ab32370) was used in western blot on human samples (fig 5a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (E18)
  • western blot; human; loading ...; fig 8
Abcam Bcl2l1 antibody (Abcam, ab32370) was used in western blot on human samples (fig 8). Biomolecules (2020) ncbi
domestic rabbit monoclonal (EPR16642)
  • western blot; rat; 1:10,000; loading ...; fig 6d
Abcam Bcl2l1 antibody (Abcam, ab178844) was used in western blot on rat samples at 1:10,000 (fig 6d). Behav Brain Res (2019) ncbi
domestic rabbit monoclonal (E18)
  • western blot; human; loading ...; fig 3a
Abcam Bcl2l1 antibody (ABcam, ab32370) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (E18)
  • western blot; human; 1:500; fig 2
Abcam Bcl2l1 antibody (Abcam, ab32370) was used in western blot on human samples at 1:500 (fig 2). Nat Commun (2016) ncbi
domestic rabbit monoclonal (E18)
  • western blot; human; 1:1000; fig 5a
Abcam Bcl2l1 antibody (Abcam, ab32370) was used in western blot on human samples at 1:1000 (fig 5a). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (E18)
  • western blot; rat; loading ...; fig 5c
Abcam Bcl2l1 antibody (Abcam, ab32370) was used in western blot on rat samples (fig 5c). Evid Based Complement Alternat Med (2015) ncbi
domestic rabbit monoclonal (E18)
  • western blot; human; fig 1
Abcam Bcl2l1 antibody (ABCAM, E18) was used in western blot on human samples (fig 1). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (E18)
  • western blot; human; loading ...; fig 4d
Abcam Bcl2l1 antibody (Abcam, ab32370) was used in western blot on human samples (fig 4d). Oncol Rep (2015) ncbi
domestic rabbit monoclonal (E18)
  • western blot; mouse
Abcam Bcl2l1 antibody (Abcam, ab32370) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (E18)
  • western blot; human; fig 4
Abcam Bcl2l1 antibody (Abcam, ab32370) was used in western blot on human samples (fig 4). Mol Med Rep (2014) ncbi
Invitrogen
mouse monoclonal (2H12)
  • immunohistochemistry; human; 1:200; loading ...; fig 4d
Invitrogen Bcl2l1 antibody (Thermo Fisher, AHO0222) was used in immunohistochemistry on human samples at 1:200 (fig 4d). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (C.85.1)
  • western blot; rat; 1:2000; loading ...; fig 8
Invitrogen Bcl2l1 antibody (Thermo Scientific, MA-5-15142) was used in western blot on rat samples at 1:2000 (fig 8). BMC Cancer (2019) ncbi
R&D Systems
domestic rabbit monoclonal (2052A)
  • western blot; mouse; 1:1000; loading ...; fig 4e
R&D Systems Bcl2l1 antibody (R&D Systems, MAB894) was used in western blot on mouse samples at 1:1000 (fig 4e). Cell Prolif (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 5a, 5d, 5g, 5j
Cell Signaling Technology Bcl2l1 antibody (CST, 2764) was used in western blot on human samples (fig 5a, 5d, 5g, 5j). Cell Oncol (Dordr) (2022) ncbi
domestic rabbit monoclonal (54H6)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1c
  • western blot; human; loading ...; fig 1b, 2a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in immunohistochemistry - paraffin section on human samples (fig 1c) and in western blot on human samples (fig 1b, 2a). Cell Oncol (Dordr) (2022) ncbi
domestic rabbit polyclonal
  • other; mouse; loading ...; fig 6p, 7p
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2762) was used in other on mouse samples (fig 6p, 7p). Autophagy (2022) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; 1:1000; loading ...; fig 3e
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples at 1:1000 (fig 3e). Immunity (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:150; loading ...; fig 5e
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Tech, CST-2762) was used in immunohistochemistry on mouse samples at 1:150 (fig 5e). Cells (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; loading ...; fig s4c
Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 2764S) was used in western blot on mouse samples (fig s4c). Redox Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 8f
Cell Signaling Technology Bcl2l1 antibody (Cell Signalling, 2762) was used in western blot on human samples at 1:1000 (fig 8f). NPJ Breast Cancer (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig 2c
Cell Signaling Technology Bcl2l1 antibody (CST, 2764) was used in western blot on human samples at 1:1000 (fig 2c). Nat Commun (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; 1:1000; loading ...; fig 1l
Cell Signaling Technology Bcl2l1 antibody (CST, 2764T) was used in western blot on mouse samples at 1:1000 (fig 1l). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot knockout validation; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Bcl2l1 antibody (CST, 2764) was used in western blot knockout validation on human samples at 1:1000 (fig 3a). Proc Natl Acad Sci U S A (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on human samples (fig 2c). Genes (Basel) (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2762) was used in western blot on mouse samples (fig 4a). Cell Death Differ (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 6a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 6a). Oncogenesis (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig s5b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig s5b). Sci Adv (2021) ncbi
domestic rabbit monoclonal (C78F1)
  • immunoprecipitation; human; loading ...; fig 5f
  • western blot; human; loading ...; fig 5f
  • western blot knockout validation; mouse; loading ...; fig 6c
  • immunoprecipitation; mouse; loading ...; fig 5a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 4237) was used in immunoprecipitation on human samples (fig 5f), in western blot on human samples (fig 5f), in western blot knockout validation on mouse samples (fig 6c) and in immunoprecipitation on mouse samples (fig 5a). Signal Transduct Target Ther (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig s2a
Cell Signaling Technology Bcl2l1 antibody (CST, 2764) was used in western blot on human samples (fig s2a). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; loading ...; fig 2a
Cell Signaling Technology Bcl2l1 antibody (CST, 2764) was used in western blot on mouse samples (fig 2a). Sci Rep (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; 1:2000; loading ...; fig 6s1a
Cell Signaling Technology Bcl2l1 antibody (CST, 2764) was used in western blot on mouse samples at 1:2000 (fig 6s1a). elife (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on human samples (fig 3d). Oncogene (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; loading ...; fig 8o
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples (fig 8o). Nat Commun (2021) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig 2e
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples at 1:1000 (fig 2e). elife (2020) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig 5s1a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples at 1:1000 (fig 5s1a). elife (2020) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples (fig 3d). Theranostics (2020) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples at 1:1000 (fig 5a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 8
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764S) was used in western blot on human samples (fig 8). Biomolecules (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2762) was used in western blot on human samples (fig 1b). Open Biol (2019) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig s5l
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples (fig s5l). Cell (2019) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 3s2e
Cell Signaling Technology Bcl2l1 antibody (CST, 54H6) was used in western blot on human samples (fig 3s2e). elife (2019) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; loading ...; fig 4d
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764P) was used in western blot on mouse samples (fig 4d). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (C78F1)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig s1c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, C78F1) was used in western blot knockout validation on mouse samples at 1:1000 (fig s1c). Nat Commun (2019) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; loading ...; fig 3a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples (fig 3a). Science (2019) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples at 1:1000 (fig 3a). Int J Oncol (2019) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764S) was used in western blot on human samples (fig 4c). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (54H6)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1d
Cell Signaling Technology Bcl2l1 antibody (CST, 2764) was used in immunohistochemistry - paraffin section on mouse samples (fig 1d). Nat Commun (2019) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 4e
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 4e). BMC Cancer (2019) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; 1:1000; loading ...; fig 3a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764S) was used in western blot on mouse samples at 1:1000 (fig 3a). elife (2018) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764T) was used in western blot on human samples at 1:1000 (fig 5a). J Biol Chem (2018) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples (fig 3b). Oncoimmunology (2018) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2762) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; fig s3a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples at 1:1000 (fig s3a). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2762) was used in western blot on human samples (fig 3a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples (fig 3c). J Exp Med (2018) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; loading ...; fig 6d
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples (fig 6d). Oncotarget (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig s4a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples at 1:1000 (fig s4a). Nat Med (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; rat; 1:1000; loading ...; fig 7c
Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 2764) was used in western blot on rat samples at 1:1000 (fig 7c). Neuropharmacology (2018) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig 4e
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on human samples at 1:1000 (fig 4e). Hepatology (2017) ncbi
domestic rabbit monoclonal (C78F1)
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology Bcl2l1 antibody (cell signalling, C78F1) was used in western blot on mouse samples (fig 5a). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig 2e
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples at 1:1000 (fig 2e). J Drug Target (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; loading ...; fig 2c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on mouse samples (fig 2c). Nat Med (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples (fig 4b). Anticancer Res (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:10,000; loading ...; fig 8a
Cell Signaling Technology Bcl2l1 antibody (cell signalling, 2764) was used in western blot on human samples at 1:10,000 (fig 8a). Int J Oncol (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 2b
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology Bcl2l1 antibody (cell signalling, 2764) was used in western blot on human samples (fig 2b). Cell Death Dis (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology Bcl2l1 antibody (CST, 2762) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit monoclonal (C78F1)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 4237) was used in western blot on human samples (fig 3c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 2764) was used in western blot on human samples (fig 6a). Nat Commun (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; 1:3000; loading ...; fig 1a
  • western blot; human; 1:3000; loading ...; fig 1b
In order to demonstrate a crosstalk between stromal fibroblasts and epithelial cells under starvation, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples at 1:3000 (fig 1a) and in western blot on human samples at 1:3000 (fig 1b). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2762) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5
In order to elucidate a mutually regulatory relationship between signal transducer and activator of transcription 5 and nucleophosmin, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2762) was used in western blot on human samples (fig 5). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s3
In order to explore the impact of SNHG5 in colorectal cancer, Cell Signaling Technology Bcl2l1 antibody (cell signalling, 2762) was used in western blot on human samples (fig s3). Nat Commun (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Bcl2l1 antibody (cell signalling, 2764) was used in western blot on human samples (fig 5a). PLoS Med (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 2d
In order to explore the role of chaperone-mediated autophagy in non-small-cell lung cancer, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on human samples (fig 2d). Biochem Biophys Res Commun (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 2b). Int J Biochem Cell Biol (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 3e
In order to explore the contribution of STAT6 phosphorylation to Graves' disease and study its role in thyroid epithelial cells, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples (fig 3e). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 3a
In order to find and characterize Mcl-1 inhibitors that cause caspase activation, mitochondrial depolarization, and selective growth inhibition, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 3a). FEBS Lett (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 2
In order to report the effects of NVP-CGM097 on the p53wildtype GOT1 cells, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 2). Neuroendocrinology (2018) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; fig 1a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on human samples at 1:1000 (fig 1a). Front Immunol (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764S) was used in western blot on human samples (fig 3b). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; dogs; loading ...; tbl 1
In order to report the changes associated with gonadotropin-releasing hormone agonist treatment, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2762) was used in western blot on dogs samples (tbl 1). Mol Reprod Dev (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; Spodoptera litura; fig 5j
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764S) was used in western blot on Spodoptera litura samples (fig 5j). Sci Rep (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 10a
In order to study chaperome complexes in a large set of tumor specimens, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 10a). Nature (2016) ncbi
domestic rabbit monoclonal (54H6)
  • immunohistochemistry knockout validation; mouse; fig 1
  • western blot knockout validation; mouse; fig 1
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in immunohistochemistry knockout validation on mouse samples (fig 1) and in western blot knockout validation on mouse samples (fig 1). Mol Cell Neurosci (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples at 1:1000 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 7b). Cancer Res (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig s4b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig s4b). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 4c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 4b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples (fig 4b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • immunohistochemistry - frozen section; rat; 1:300; fig 2
In order to elucidate the mechanism by which Brn3b protects retinal ganglion cells, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in immunohistochemistry - frozen section on rat samples at 1:300 (fig 2). Mol Vis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Tech, 2762S) was used in western blot on human samples (fig 7). Sci Rep (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 7a
In order to propose that ABHD5 has a PNPLA2-independent function in regulating autophagy and tumorigenesis, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 7a). Autophagy (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 4b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s2
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Tech, 2762) was used in western blot on human samples (fig s2). Oncoimmunology (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Tech, 2762S) was used in western blot on human samples at 1:1000 (fig 5). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (54H6)
  • flow cytometry; mouse; loading ...; fig 6
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Cell Signaling Technology Bcl2l1 antibody (cell signalling, 54H6) was used in flow cytometry on mouse samples (fig 6). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 2
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 2). Cancer Cell Int (2016) ncbi
domestic rabbit monoclonal (54H6)
  • immunohistochemistry; human; 1:1000; fig 3
  • western blot; human; 1:1000; fig 4
In order to study the transduction of MITF-driven prosurvival signals by BPTF in melanoma cells, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in immunohistochemistry on human samples at 1:1000 (fig 3) and in western blot on human samples at 1:1000 (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to study promotion of survival of breast cancer cells in response to hyper-fractionated radiation treatment by RAC1 GTPase, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2762) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 4
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 4). Mol Brain (2016) ncbi
domestic rabbit monoclonal (54H6)
  • flow cytometry; human; loading ...; fig s2
Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 2767) was used in flow cytometry on human samples (fig s2). Oncotarget (2017) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; loading ...; fig s1b
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on mouse samples (fig s1b). Nature (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 1
  • western blot; mouse; fig 1
In order to elucidate inhibition of BCL-W and BCL-XL by directed elimination of senescent cells, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 1) and in western blot on mouse samples (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 4a
In order to elucidate the mechanism of cisplatin-induced non-small-cell lung cancer cell apoptosis, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on human samples (fig 4a). Biochem Biophys Res Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2762) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
domestic rabbit monoclonal (54H6)
  • immunoprecipitation; human; fig 5
  • immunocytochemistry; human; fig 5
  • western blot; human; fig 5
Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 2764p) was used in immunoprecipitation on human samples (fig 5), in immunocytochemistry on human samples (fig 5) and in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; fig 2
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technolog, 2764) was used in western blot on mouse samples (fig 2). Cell Death Differ (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples (fig 5a). J Immunol (2016) ncbi
domestic rabbit monoclonal (C78F1)
  • western blot; mouse; loading ...; fig 5b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 4237) was used in western blot on mouse samples (fig 5b). J Immunol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Tech, 2762) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; fig 1
In order to investigate the effect of Obatoclax in esophageal cancer cells, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Tech, 2764) was used in western blot on human samples at 1:1000 (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 7
In order to investigate survival and neuronal differentiation of human BM-MSCs by pulsed electromagnetic fields, Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 2764S) was used in western blot on human samples (fig 7). Life Sci (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 5
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • immunocytochemistry; human; fig 4
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples at 1:1000 (fig 5). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 6d
In order to study quinacrine-induced apoptosis, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 6d). Biochem Pharmacol (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 4
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; 1:1000; fig s1
  • immunohistochemistry - paraffin section; human; 1:500; fig 9
In order to show that Bcl-xL promotes metastasis independent of its anti-apoptotic activity, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on mouse samples at 1:1000 (fig s1) and in immunohistochemistry - paraffin section on human samples at 1:500 (fig 9). Nat Commun (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 3
In order to elucidate the deubiquitinase inhibitor PR-619 and how it sensitizes normal human fibroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell death, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 3). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 6
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 5
Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 2764) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 2
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764S) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig s11
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples (fig s11). Cell Mol Life Sci (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 1
In order to study the effects of HDAC inhibitors and BCL-2 inhibitors on small cell lung cancer lines, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on human samples (fig 1). Cancer Biol Ther (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:5000; fig 2h
In order to assess the definition of obligate participation in multiple hallmarks of cancer by a comprehensive functional characterization of cancer-testis antigens, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples at 1:5000 (fig 2h). Nat Commun (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; fig 5a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on mouse samples (fig 5a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; fig 5
In order to study the role of autophagy during pancreatitis, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples (fig 5). Proc Natl Acad Sci U S A (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; fig 6
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764 s) was used in western blot on mouse samples (fig 6). Cell Death Differ (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; fig 3d
In order to report that an inhibitor of the bromodomain and extraterminal family of proteins suppresses pancreatic ductal adenocarcinoma, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples at 1:1000 (fig 3d). Nat Med (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; African green monkey; 1:1000; loading ...; fig 5a
Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 54H6) was used in western blot on African green monkey samples at 1:1000 (fig 5a). Antiviral Res (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; rat; loading ...; fig 4e
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on rat samples (fig 4e). Cell Mol Neurobiol (2016) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; fig 6b
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples (fig 6b). J Biol Chem (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; 1:200; fig 9
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples at 1:200 (fig 9). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 2764) was used in western blot on human samples at 1:1000 (fig 3). Nat Commun (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; loading ...; fig 3c
  • western blot; mouse; 1:1000; loading ...; fig 5c
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples at 1:1000 (fig 3c) and in western blot on mouse samples at 1:1000 (fig 5c). Mol Med Rep (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; loading ...; fig 3i
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples (fig 3i). Nat Genet (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 2a
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on human samples (fig 2a). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 5
In order to elucidate how PLK1 regulates cell survival during mTORC1 hyperactivation, Cell Signaling Technology Bcl2l1 antibody (Cell signaling, 2764) was used in western blot on human samples (fig 5). Cell Cycle (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; 1:1000; fig 7
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on mouse samples at 1:1000 (fig 7). PLoS ONE (2014) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; rat; 1:1000
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 54H6) was used in western blot on rat samples at 1:1000. Neurochem Res (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000; tbl 1
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 2764) was used in western blot on human samples at 1:1000 (tbl 1). Methods Mol Biol (2015) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; rat; 1:500
Cell Signaling Technology Bcl2l1 antibody (CST, 54H6) was used in western blot on rat samples at 1:500. Exp Eye Res (2014) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:500
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling, 54H6) was used in western blot on human samples at 1:500. J Biol Chem (2014) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; fig 1
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 2764) was used in western blot on human samples (fig 1). Cell Tissue Res (2014) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human
In order to evaluate the effect of Noxa on the localization and stability of MCL-1 in small cell lung cancer, Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technology, 54H6) was used in western blot on human samples . Cell Death Dis (2014) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; mouse; fig s2
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Tech, 2764) was used in western blot on mouse samples (fig s2). Autophagy (2014) ncbi
domestic rabbit monoclonal (54H6)
  • western blot; human; 1:1000
Cell Signaling Technology Bcl2l1 antibody (Cell Signaling Technologies, 54H6) was used in western blot on human samples at 1:1000. Cell Death Differ (2013) ncbi
BD Biosciences
mouse monoclonal (44/Bcl-x)
  • western blot; human; 1:1000; loading ...; fig 2a
BD Biosciences Bcl2l1 antibody (BD, 610746) was used in western blot on human samples at 1:1000 (fig 2a). Cell Death Dis (2018) ncbi
mouse monoclonal (44/Bcl-x)
  • western blot; mouse; loading ...; fig s5
BD Biosciences Bcl2l1 antibody (BD Bioscience, 44/BCL-X) was used in western blot on mouse samples (fig s5). J Clin Invest (2017) ncbi
mouse monoclonal (4/Bcl-x)
  • western blot; human; loading ...; fig s3f
BD Biosciences Bcl2l1 antibody (BD Biosciences, 610210) was used in western blot on human samples (fig s3f). Autophagy (2017) ncbi
mouse monoclonal (44/Bcl-x)
  • western blot; human; fig 4
BD Biosciences Bcl2l1 antibody (BD Biosciences, 610746) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
mouse monoclonal (44/Bcl-x)
  • western blot; human; 1:1000; fig 8
BD Biosciences Bcl2l1 antibody (BD Bioscience, 610747) was used in western blot on human samples at 1:1000 (fig 8). Oncotarget (2015) ncbi
mouse monoclonal (44/Bcl-x)
  • western blot; mouse; 1:100; fig 6d, 6e
BD Biosciences Bcl2l1 antibody (BD Transduction Laboratories, 610747) was used in western blot on mouse samples at 1:100 (fig 6d, 6e). FEBS Open Bio (2015) ncbi
mouse monoclonal (4/Bcl-x)
  • western blot; human; fig 3
BD Biosciences Bcl2l1 antibody (Transduction Lab, 610209) was used in western blot on human samples (fig 3). Cancer Biol Ther (2015) ncbi
mouse monoclonal (4/Bcl-x)
  • western blot; mouse
BD Biosciences Bcl2l1 antibody (BD Biosciences, 610210) was used in western blot on mouse samples . Methods Enzymol (2009) ncbi
Articles Reviewed
  1. Tao M, Ma H, Fu X, Wang C, Li Y, Hu X, et al. Semaphorin 3F induces colorectal cancer cell chemosensitivity by promoting P27 nuclear export. Front Oncol. 2022;12:899927 pubmed publisher
  2. Shu W, Zhu X, Wang K, Cherepanoff S, Conway R, Madigan M, et al. The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma. Cell Oncol (Dordr). 2022;45:601-619 pubmed publisher
  3. Cyra M, Schulte M, Berthold R, Heinst L, Jansen E, Gr xfc newald I, et al. SS18-SSX drives CREB activation in synovial sarcoma. Cell Oncol (Dordr). 2022;45:399-413 pubmed publisher
  4. Vessey K, Jobling A, Tran M, Wang A, Greferath U, Fletcher E. Treatments targeting autophagy ameliorate the age-related macular degeneration phenotype in mice lacking APOE (apolipoprotein E). Autophagy. 2022;18:2368-2384 pubmed publisher
  5. Simpson D, Pang J, Weir A, Kong I, Fritsch M, Rashidi M, et al. Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway. Immunity. 2022;55:423-441.e9 pubmed publisher
  6. Wu C, Wang Y, Hu S, Wu W, Yeh C, Bamodu O. MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590. Front Oncol. 2021;11:744937 pubmed publisher
  7. Mangold N, Pippin J, Unnersjoe Jess D, Koehler S, Shankland S, Brähler S, et al. The Atypical Cyclin-Dependent Kinase 5 (Cdk5) Guards Podocytes from Apoptosis in Glomerular Disease While Being Dispensable for Podocyte Development. Cells. 2021;10: pubmed publisher
  8. Bhattarai K, Kim H, Chaudhary M, Ur Rashid M, Kim J, Kim H, et al. TMBIM6 regulates redox-associated posttranslational modifications of IRE1α and ER stress response failure in aging mice and humans. Redox Biol. 2021;47:102128 pubmed publisher
  9. Gyamfi J, Yeo J, Kwon D, Min B, Cha Y, Koo J, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer. 2021;7:129 pubmed publisher
  10. Goel S, Bhatia V, Kundu S, Biswas T, Carskadon S, Gupta N, et al. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression. Nat Commun. 2021;12:5325 pubmed publisher
  11. Guo T, Gu C, Li B, Xu C. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain. Aging (Albany NY). 2021;13:19750-19759 pubmed publisher
  12. Lassiter R, Merchen T, Fang X, Wang Y. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation. Front Immunol. 2021;12:671025 pubmed publisher
  13. Marquez Exposito L, Tejedor Santamaria L, Santos Sánchez L, Valentijn F, Cantero Navarro E, Rayego Mateos S, et al. Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes. Front Pharmacol. 2021;12:662020 pubmed publisher
  14. Li S, Jin H, Sun G, Zhang C, Wang J, Xu H, et al. Dietary Inorganic Nitrate Protects Hepatic Ischemia-Reperfusion Injury Through NRF2-Mediated Antioxidative Stress. Front Pharmacol. 2021;12:634115 pubmed publisher
  15. Sanchez Rivera F, Ryan J, Soto Feliciano Y, Clare Beytagh M, Xuan L, Feldser D, et al. Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  16. Nakajima W, Miyazaki K, Asano Y, Kubota S, Tanaka N. Krüppel-Like Factor 4 and Its Activator APTO-253 Induce NOXA-Mediated, p53-Independent Apoptosis in Triple-Negative Breast Cancer Cells. Genes (Basel). 2021;12: pubmed publisher
  17. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
  18. Campbell K, Mason S, Winder M, Willemsen R, Cloix C, Lawson H, et al. Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function. Cell Death Differ. 2021;: pubmed publisher
  19. Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K, et al. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis. 2021;10:25 pubmed publisher
  20. Kitamura Y, Kanaya N, Moleirinho S, Du W, Reinshagen C, Attia N, et al. Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv. 2021;7: pubmed publisher
  21. Yu Z, Li X, Yang M, Huang J, Fang Q, Jia J, et al. TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. Signal Transduct Target Ther. 2021;6:90 pubmed publisher
  22. Xu Y, Li D, Wu J, Zhang M, Shao X, Xu L, et al. Farnesoid X receptor promotes renal ischaemia-reperfusion injury by inducing tubular epithelial cell apoptosis. Cell Prolif. 2021;54:e13005 pubmed publisher
  23. Shen X, Wang H, Weng C, Jiang H, Chen J. Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity. Cell Death Dis. 2021;12:186 pubmed publisher
  24. Nozaki Y, Hikita H, Tanaka S, Fukumoto K, Urabe M, Sato K, et al. Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration. Sci Rep. 2021;11:3363 pubmed publisher
  25. Li Y, Ritchie E, Steinke C, Qi C, Chen L, Zheng B, et al. Activation of MAP3K DLK and LZK in Purkinje cells causes rapid and slow degeneration depending on signaling strength. elife. 2021;10: pubmed publisher
  26. Kuo T, Wu M, Yang S, Chen S, Hsu T, Jhuang J, et al. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv. Oncogene. 2021;40:1242-1254 pubmed publisher
  27. Gladka M, Kohela A, Molenaar B, Versteeg D, Kooijman L, Monshouwer Kloots J, et al. Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner. Nat Commun. 2021;12:84 pubmed publisher
  28. Ruan H, Li X, Xu X, Leibowitz B, Tong J, Chen L, et al. eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis. elife. 2020;9: pubmed publisher
  29. Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk S. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. elife. 2020;9: pubmed publisher
  30. Han B, Meng X, Wu P, Li Z, Li S, Zhang Y, et al. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma. Theranostics. 2020;10:3351-3365 pubmed publisher
  31. Bajpai R, Sharma A, Achreja A, Edgar C, Wei C, Siddiqa A, et al. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nat Commun. 2020;11:1228 pubmed publisher
  32. Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed publisher
  33. Lohard S, Bourgeois N, Maillet L, Gautier F, Fétiveau A, Lasla H, et al. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment. Nat Commun. 2020;11:259 pubmed publisher
  34. Sheng L, Zhang J, Li L, Xie X, Wen X, Cheng K. Design, Synthesis, and Evaluation of Novel 2-Methoxyestradiol Derivatives as Apoptotic Inducers Through an Intrinsic Apoptosis Pathway. Biomolecules. 2020;10: pubmed publisher
  35. Singh M, Kasna S, Roy S, Aldosary S, Saeedan A, Ansari M, et al. Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signalling. BMC Cancer. 2019;19:996 pubmed publisher
  36. Veschi V, Mangiapane L, Nicotra A, Di Franco S, Scavo E, Apuzzo T, et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene. 2020;39:987-1003 pubmed publisher
  37. Thangaraj K, Balasubramanian B, Park S, Natesan K, Liu W, Manju V. Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells. Biomolecules. 2019;9: pubmed publisher
  38. Littler S, Sloss O, Geary B, Pierce A, Whetton A, Taylor S. Oncogenic MYC amplifies mitotic perturbations. Open Biol. 2019;9:190136 pubmed publisher
  39. Zierhut C, Yamaguchi N, Paredes M, Luo J, Carroll T, Funabiki H. The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death. Cell. 2019;178:302-315.e23 pubmed publisher
  40. Kabir S, Cidado J, Andersen C, Dick C, Lin P, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. elife. 2019;8: pubmed publisher
  41. Liu F, Fan D, Yang Z, Tang N, Guo Z, Ma S, et al. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Cell Death Dis. 2019;10:480 pubmed publisher
  42. Rosenbaum M, Gewies A, Pechloff K, Heuser C, Engleitner T, Gehring T, et al. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. Nat Commun. 2019;10:2352 pubmed publisher
  43. Pan C, Jin L, Wang X, Li Y, Chun J, Boese A, et al. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. J Clin Invest. 2019;129:2431-2445 pubmed publisher
  44. He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed publisher
  45. Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R, et al. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway. Int J Oncol. 2019;54:1466-1480 pubmed publisher
  46. Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, et al. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int. 2019;19:32 pubmed publisher
  47. Haikala H, Anttila J, Marques E, Raatikainen T, Ilander M, Hakanen H, et al. Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nat Commun. 2019;10:620 pubmed publisher
  48. Li Z, Mbah N, Overmeyer J, Sarver J, George S, Trabbic C, et al. The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma. BMC Cancer. 2019;19:77 pubmed publisher
  49. LeBlanc L, Lee B, Yu A, Kim M, Kambhampati A, Dupont S, et al. Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation. elife. 2018;7: pubmed publisher
  50. Lian S, Xu B, Wang D, Wang L, Li W, Yao R, et al. Possible mechanisms of prenatal cold stress induced-anxiety-like behavior depression in offspring rats. Behav Brain Res. 2019;359:304-311 pubmed publisher
  51. De R, Sarkar S, Mazumder S, Debsharma S, Siddiqui A, Saha S, et al. Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-κB signaling. J Biol Chem. 2018;293:19740-19760 pubmed publisher
  52. Wu R, Yang H, Wan J, Deng X, Chen L, Hao S, et al. Knockdown of the Hippo transducer YAP reduces proliferation and promotes apoptosis in the Jurkat leukemia cell. Mol Med Rep. 2018;18:5379-5388 pubmed publisher
  53. Yue D, Sun X. Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma. Cell Death Dis. 2018;9:935 pubmed publisher
  54. Hobeika E, Dautzenberg M, Levit Zerdoun E, Pelanda R, Reth M. Conditional Selection of B Cells in Mice With an Inducible B Cell Development. Front Immunol. 2018;9:1806 pubmed publisher
  55. Yang M, Li C, Zhu S, Cao L, Kroemer G, Zeh H, et al. TFAM is a novel mediator of immunogenic cancer cell death. Oncoimmunology. 2018;7:e1431086 pubmed publisher
  56. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  57. Zhang S, Zhang M, Jing Y, Yin X, Ma P, Zhang Z, et al. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors. Nat Commun. 2018;9:215 pubmed publisher
  58. Bogenberger J, Whatcott C, Hansen N, Delman D, Shi C, Kim W, et al. Combined venetoclax and alvocidib in acute myeloid leukemia. Oncotarget. 2017;8:107206-107222 pubmed publisher
  59. Hogstad B, Berres M, Chakraborty R, Tang J, Bigenwald C, Serasinghe M, et al. RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. J Exp Med. 2018;215:319-336 pubmed publisher
  60. Kim M, Morales L, Baek M, Slaga T, DiGiovanni J, Kim D. UVB-induced nuclear translocation of TC-PTP by AKT/14-3-3? axis inhibits keratinocyte survival and proliferation. Oncotarget. 2017;8:90674-90692 pubmed publisher
  61. Zhao L, Liu J, He C, Yan R, Zhou K, Cui Q, et al. Protein kinase A determines platelet life span and survival by regulating apoptosis. J Clin Invest. 2017;127:4338-4351 pubmed publisher
  62. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher
  63. Xie Z, Enkhjargal B, Wu L, Zhou K, Sun C, Hu X, et al. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology. 2018;128:142-151 pubmed publisher
  64. Moncsek A, Al Suraih M, Trussoni C, O Hara S, Splinter P, Zuber C, et al. Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice. Hepatology. 2017;: pubmed publisher
  65. Lan P, Fan Y, Zhao Y, Lou X, Monsour H, Zhang X, et al. TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury. J Clin Invest. 2017;127:2222-2234 pubmed publisher
  66. Yang X, Zhao Q, Yin H, Lei X, Gan R. MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression. J Drug Target. 2017;25:653-660 pubmed publisher
  67. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  68. Jelinek M, Kabelova A, Srámek J, Seitz J, Ojima I, Kovar J. Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Res. 2017;37:1581-1590 pubmed
  69. Yokoyama T, Kohn E, Brill E, Lee J. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 2017;: pubmed publisher
  70. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  71. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  72. Mondello P, Derenzini E, Asgari Z, Philip J, Brea E, SESHAN V, et al. Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma. Oncotarget. 2017;8:14017-14028 pubmed publisher
  73. Cayrol F, Praditsuktavorn P, Fernando T, Kwiatkowski N, Marullo R, Calvo Vidal M, et al. THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14290 pubmed publisher
  74. Adams C, Kim A, Mitra R, Choi J, Gong J, Eischen C. BCL-W has a fundamental role in B cell survival and lymphomagenesis. J Clin Invest. 2017;127:635-650 pubmed publisher
  75. Muranen T, Iwanicki M, Curry N, Hwang J, DuBois C, Coloff J, et al. Starved epithelial cells uptake extracellular matrix for survival. Nat Commun. 2017;8:13989 pubmed publisher
  76. Eritja N, Chen B, Rodríguez Barrueco R, Santacana M, Gatius S, Vidal A, et al. Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer. Autophagy. 2017;13:608-624 pubmed publisher
  77. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  78. Ren Z, Aerts J, Vandenplas H, Wang J, Gorbenko O, Chen J, et al. Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2. Cell Death Dis. 2016;7:e2560 pubmed publisher
  79. Damas N, Marcatti M, Come C, Christensen L, Nielsen M, Baumgartner R, et al. SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization. Nat Commun. 2016;7:13875 pubmed publisher
  80. Li Y, Buijs Gladdines J, Cant Barrett K, Stubbs A, Vroegindeweij E, Smits W, et al. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. PLoS Med. 2016;13:e1002200 pubmed publisher
  81. Suzuki J, Nakajima W, Suzuki H, Asano Y, Tanaka N. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1. Biochem Biophys Res Commun. 2017;482:1334-1340 pubmed publisher
  82. Park S, Jwa E, Shin S, Ju E, Park I, Pak J, et al. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage. Int J Biochem Cell Biol. 2017;83:47-55 pubmed publisher
  83. Jiang X, Zha B, Liu X, Liu R, Liu J, Huang E, et al. STAT6 deficiency ameliorates Graves' disease severity by suppressing thyroid epithelial cell hyperplasia. Cell Death Dis. 2016;7:e2506 pubmed publisher
  84. Lee T, Bian Z, Zhao B, Hogdal L, Sensintaffar J, Goodwin C, et al. Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors. FEBS Lett. 2017;591:240-251 pubmed publisher
  85. Reuther C, Heinzle V, Nölting S, Herterich S, Hahner S, Halilovic E, et al. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. Neuroendocrinology. 2018;106:1-19 pubmed publisher
  86. Schafer C, Göder A, Beyer M, Kiweler N, Mahendrarajah N, Rauch A, et al. Class I histone deacetylases regulate p53/NF-?B crosstalk in cancer cells. Cell Signal. 2017;29:218-225 pubmed publisher
  87. Pandey R, Mehrotra S, Sharma S, Gudde R, Sundar S, Shaha C. Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival. Front Immunol. 2016;7:456 pubmed
  88. Berthenet K, Bokhari A, Lagrange A, Marcion G, Boudesco C, Causse S, et al. HSP110 promotes colorectal cancer growth through STAT3 activation. Oncogene. 2017;36:2328-2336 pubmed publisher
  89. Bulldan A, Shihan M, Goericke Pesch S, Scheiner Bobis G. Signaling events associated with gonadotropin releasing hormone-agonist-induced hormonal castration and its reversal in canines. Mol Reprod Dev. 2016;83:1092-1101 pubmed publisher
  90. Shao X, Lai D, Zhang L, Xu H. Induction of Autophagy and Apoptosis via PI3K/AKT/TOR Pathways by Azadirachtin A in Spodoptera litura Cells. Sci Rep. 2016;6:35482 pubmed publisher
  91. Rodina A, Wang T, Yan P, Gomes E, Dunphy M, Pillarsetty N, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016;538:397-401 pubmed publisher
  92. Fogarty L, Song B, Suppiah Y, Hasan S, Martin H, Hogan S, et al. Bcl-xL dependency coincides with the onset of neurogenesis in the developing mammalian spinal cord. Mol Cell Neurosci. 2016;77:34-46 pubmed publisher
  93. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  94. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  95. Klingbeil O, Lesche R, Gelato K, Haendler B, Lejeune P. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death Dis. 2016;7:e2365 pubmed publisher
  96. Heulot M, Chevalier N, Puyal J, Margue C, Michel S, Kreis S, et al. The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner. Oncotarget. 2016;7:64342-64359 pubmed publisher
  97. Park S, Jo D, Jo S, Shin D, Shim S, Jo Y, et al. Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death. Oncotarget. 2016;7:65957-65967 pubmed publisher
  98. Phatak N, Stankowska D, Krishnamoorthy R. Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma. Mol Vis. 2016;22:1048-61 pubmed
  99. Duggan S, Behan F, Kirca M, Zaheer A, McGarrigle S, Reynolds J, et al. The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival. Sci Rep. 2016;6:32638 pubmed publisher
  100. Peng Y, Miao H, Wu S, Yang W, Zhang Y, Xie G, et al. ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2. Autophagy. 2016;12:2167-2182 pubmed
  101. Wu J, Wu H, Tsai D, Chiang M, Chen Y, Gao S, et al. Temporal regulation of Lsp1 O-GlcNAcylation and phosphorylation during apoptosis of activated B cells. Nat Commun. 2016;7:12526 pubmed publisher
  102. Jinesh G, Molina J, Huang L, Laing N, Mills G, Bar Eli M, et al. Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis. Cell Death Discov. 2016;2:16003 pubmed publisher
  103. Shi Y, He Z, Jia Z, Xu C. Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo. Mol Med Rep. 2016;14:2921-8 pubmed publisher
  104. Weyhenmeyer B, Noonan J, Würstle M, Lincoln F, Johnston G, Rehm M, et al. Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide. Oncotarget. 2016;7:61295-61311 pubmed publisher
  105. Liu H, Li W, Yu X, Gao F, Duan Z, Ma X, et al. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Oncotarget. 2016;7:56338-56354 pubmed publisher
  106. Franzese O, Palermo B, Di Donna C, Sperduti I, Ferraresi V, Stabile H, et al. Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS. Oncoimmunology. 2016;5:e1114203 pubmed publisher
  107. Bao H, Liu P, Jiang K, Zhang X, Xie L, Wang Z, et al. Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol Lett. 2016;12:1058-1066 pubmed
  108. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  109. Tagscherer K, Fassl A, Sinkovic T, Richter J, Schecher S, Macher Goeppinger S, et al. MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen. Cancer Cell Int. 2016;16:42 pubmed publisher
  110. Dar A, Majid S, Bezrookove V, Phan B, Ursu S, Nosrati M, et al. BPTF transduces MITF-driven prosurvival signals in melanoma cells. Proc Natl Acad Sci U S A. 2016;113:6254-8 pubmed publisher
  111. Hein A, Post C, Sheinin Y, Lakshmanan I, Natarajan A, Enke C, et al. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Oncogene. 2016;35:6319-6329 pubmed publisher
  112. Zhao J, Niu X, Li X, Edwards H, Wang G, Wang Y, et al. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. Oncotarget. 2016;7:34785-99 pubmed publisher
  113. Wang W, Zhan M, Li Q, Chen W, Chu H, Huang Q, et al. FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression. Oncotarget. 2016;7:34617-29 pubmed publisher
  114. Kim H, Oh J, Choi S, Nam Y, Jo A, Kwon A, et al. Down-regulation of p21-activated serine/threonine kinase 1 is involved in loss of mesencephalic dopamine neurons. Mol Brain. 2016;9:45 pubmed publisher
  115. Pallis M, Burrows F, Ryan J, Grundy M, Seedhouse C, Abdul Aziz A, et al. Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells. Oncotarget. 2017;8:16220-16232 pubmed publisher
  116. Venkatesan N, Kanwar J, Deepa P, Navaneethakrishnan S, Joseph C, Krishnakumar S. Targeting HSP90/Survivin using a cell permeable structure based peptido-mimetic shepherdin in retinoblastoma. Chem Biol Interact. 2016;252:141-9 pubmed publisher
  117. O Neill K, Huang K, Zhang J, Chen Y, Luo X. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane. Genes Dev. 2016;30:973-88 pubmed publisher
  118. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  119. Yosef R, Pilpel N, Tokarsky Amiel R, Biran A, Ovadya Y, Cohen S, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016;7:11190 pubmed publisher
  120. Matsumoto M, Nakajima W, Seike M, Gemma A, Tanaka N. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells. Biochem Biophys Res Commun. 2016;473:490-6 pubmed publisher
  121. Afsar T, Trembley J, Salomon C, Razak S, Khan M, Ahmed K. Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways. Sci Rep. 2016;6:23077 pubmed publisher
  122. Qiao C, Lu N, Zhou Y, Ni T, Dai Y, Li Z, et al. Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53. Oncotarget. 2016;7:17009-20 pubmed publisher
  123. Barroso González J, Auclair S, Luan S, Thomas L, Atkins K, Aslan J, et al. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ. 2016;23:1448-57 pubmed publisher
  124. Naik E, Dixit V. Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCβ Kinase Activity. J Immunol. 2016;196:3438-51 pubmed publisher
  125. Gilormini M, Malesys C, Armandy E, Manas P, Guy J, Magne N, et al. Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC. Oncotarget. 2016;7:16731-44 pubmed publisher
  126. Yu L, Wu W, Gu C, Zhong D, Zhao X, Kong Y, et al. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells. Oncotarget. 2016;7:14693-707 pubmed publisher
  127. Urnukhsaikhan E, Cho H, Mishig Ochir T, Seo Y, Park J. Pulsed electromagnetic fields promote survival and neuronal differentiation of human BM-MSCs. Life Sci. 2016;151:130-138 pubmed publisher
  128. Stojcheva N, Schechtmann G, Sass S, Roth P, Florea A, Stefanski A, et al. MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. Oncotarget. 2016;7:12937-50 pubmed publisher
  129. Zámbó V, Tóth M, Schlachter K, Szelényi P, Sarnyai F, Lotz G, et al. Cytosolic localization of NADH cytochrome b₅ oxidoreductase (Ncb5or). FEBS Lett. 2016;590:661-71 pubmed publisher
  130. Park J, Park J, Park D, Kim D, Kim H. Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer. Stem Cells. 2016;34:1177-87 pubmed publisher
  131. Zhang J, Liu J, Li H, Wang J. β-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl. Mol Med Rep. 2016;13:2543-51 pubmed publisher
  132. Preet R, Siddharth S, Satapathy S, Das S, Nayak A, Das D, et al. Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade. Biochem Pharmacol. 2016;105:23-33 pubmed publisher
  133. De Toni E, Ziesch A, Rizzani A, Török H, Hocke S, Lü S, et al. Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis. Oncotarget. 2016;7:9477-90 pubmed publisher
  134. Lopez J, Bessou M, Riley J, Giampazolias E, Todt F, Rochegüe T, et al. Mito-priming as a method to engineer Bcl-2 addiction. Nat Commun. 2016;7:10538 pubmed publisher
  135. Choi S, Chen Z, Tang L, Fang Y, Shin S, Panarelli N, et al. Bcl-xL promotes metastasis independent of its anti-apoptotic activity. Nat Commun. 2016;7:10384 pubmed publisher
  136. Crowder R, Dicker D, El Deiry W. The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death. J Biol Chem. 2016;291:5960-70 pubmed publisher
  137. Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7:4062-76 pubmed publisher
  138. Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed publisher
  139. Jia Z, Wang J, Shi Q, Liu S, Wang W, Tian Y, et al. SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition. Apoptosis. 2016;21:174-83 pubmed publisher
  140. Dupont T, Yang S, Patel J, Hatzi K, Malik A, Tam W, et al. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma. Oncotarget. 2016;7:3520-32 pubmed publisher
  141. Shishkina G, Kalinina T, Bulygina V, Lanshakov D, Babluk E, Dygalo N. Anti-Apoptotic Protein Bcl-xL Expression in the Midbrain Raphe Region Is Sensitive to Stress and Glucocorticoids. PLoS ONE. 2015;10:e0143978 pubmed publisher
  142. Green A, Maciel T, Hospital M, Yin C, Mazed F, Townsend E, et al. Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia. Sci Adv. 2015;1:e1500221 pubmed publisher
  143. Messner B, Türkcan A, Ploner C, Laufer G, Bernhard D. Cadmium overkill: autophagy, apoptosis and necrosis signalling in endothelial cells exposed to cadmium. Cell Mol Life Sci. 2016;73:1699-713 pubmed publisher
  144. Nakajima W, Sharma K, Hicks M, Le N, Brown R, Krystal G, et al. Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer. Cancer Biol Ther. 2016;17:27-35 pubmed publisher
  145. Maxfield K, Taus P, Corcoran K, Wooten J, Macion J, Zhou Y, et al. Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer. Nat Commun. 2015;6:8840 pubmed publisher
  146. Wang J, De Veirman K, De Beule N, Maes K, De Bruyne E, Van Valckenborgh E, et al. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells. Oncotarget. 2015;6:43992-4004 pubmed publisher
  147. Antonucci L, Fagman J, Kim J, Todoric J, Gukovsky I, Mackey M, et al. Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress. Proc Natl Acad Sci U S A. 2015;112:E6166-74 pubmed publisher
  148. Vétillard A, Jonchère B, Moreau M, Toutain B, Henry C, Fontanel S, et al. Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis. Oncotarget. 2015;6:43342-62 pubmed publisher
  149. Kroon J, Puhr M, Buijs J, van der Horst G, Hemmer D, Marijt K, et al. Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer. Endocr Relat Cancer. 2016;23:35-45 pubmed publisher
  150. Esber N, Le Billan F, Resche Rigon M, Loosfelt H, Lombès M, Chabbert Buffet N. Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression. PLoS ONE. 2015;10:e0140795 pubmed publisher
  151. Montes M, Coiras M, Becerra S, Moreno Castro C, Mateos E, Majuelos J, et al. Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing. PLoS ONE. 2015;10:e0139812 pubmed publisher
  152. Sochalska M, Ottina E, Tuzlak S, Herzog S, Herold M, Villunger A. Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival. Cell Death Differ. 2016;23:628-39 pubmed publisher
  153. Mazur P, Herner A, Mello S, Wirth M, Hausmann S, Sánchez Rivera F, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat Med. 2015;21:1163-71 pubmed publisher
  154. Anderson K, Russell A, Foletta V. NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity. FEBS Open Bio. 2015;5:668-81 pubmed publisher
  155. Weiss R, Laengle J, Sachet M, Shurygina A, Kiselev O, Egorov A, et al. Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis. Antiviral Res. 2015;123:93-104 pubmed publisher
  156. Ramírez de Arellano A, Lopez Pulido E, Martínez Neri P, Estrada Chávez C, González Lucano R, Fafutis Morris M, et al. STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells. Cancer Cell Int. 2015;15:83 pubmed publisher
  157. Yao K, Wu J, Zhang J, Bo J, Hong Z, Zu H. Protective Effect of DHT on Apoptosis Induced by U18666A via PI3K/Akt Signaling Pathway in C6 Glial Cell Lines. Cell Mol Neurobiol. 2016;36:801-9 pubmed publisher
  158. Schmidt L, Kümmel A, Görlich D, Mohr M, Bröckling S, Mikesch J, et al. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. PLoS ONE. 2015;10:e0136023 pubmed publisher
  159. Tiffen J, Gunatilake D, Gallagher S, Gowrishankar K, Heinemann A, Cullinane C, et al. Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes. Oncotarget. 2015;6:27023-36 pubmed publisher
  160. Zhang Y, He Y, Yu H, Ma F, Wu J, Zhang X. Liquiritigenin Protects Rats from Carbon Tetrachloride Induced Hepatic Injury through PGC-1α Pathway. Evid Based Complement Alternat Med. 2015;2015:649568 pubmed publisher
  161. Liu B, Huang W, Xiao X, Xu Y, Ma S, Xia Z. Neuroprotective Effect of Ulinastatin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits. Oxid Med Cell Longev. 2015;2015:624819 pubmed publisher
  162. Patergnani S, Giorgi C, Maniero S, Missiroli S, Maniscalco P, Bononi I, et al. The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition. Oncotarget. 2015;6:23427-44 pubmed
  163. Tattikota S, Rathjen T, Hausser J, Khedkar A, Kabra U, Pandey V, et al. miR-184 Regulates Pancreatic β-Cell Function According to Glucose Metabolism. J Biol Chem. 2015;290:20284-94 pubmed publisher
  164. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  165. Kotipatruni R, Ren X, Thotala D, Jaboin J. NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells. Oncotarget. 2015;6:17594-604 pubmed
  166. Nagata T, Yasukawa H, Kyogoku S, Oba T, Takahashi J, Nohara S, et al. Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules. PLoS ONE. 2015;10:e0127942 pubmed publisher
  167. Raimondi L, De Luca A, Amodio N, Manno M, Raccosta S, Taverna S, et al. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation. Oncotarget. 2015;6:13772-89 pubmed
  168. Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015;236:43-59 pubmed publisher
  169. Haschka M, Soratroi C, Kirschnek S, Hacker G, Hilbe R, Geley S, et al. The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest. Nat Commun. 2015;6:6891 pubmed publisher
  170. McMillan E, Paré M, Baechler B, Graham D, Rush J, Quadrilatero J. Autophagic signaling and proteolytic enzyme activity in cardiac and skeletal muscle of spontaneously hypertensive rats following chronic aerobic exercise. PLoS ONE. 2015;10:e0119382 pubmed publisher
  171. Ma W, Na M, Tang C, Wang H, Lin Z. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways. Mol Med Rep. 2015;12:1050-8 pubmed publisher
  172. Yang M, Zhao H, Guo L, Zhang Q, Zhao L, Bai S, et al. Autophagy-based survival prognosis in human colorectal carcinoma. Oncotarget. 2015;6:7084-103 pubmed
  173. Morlé A, Garrido C, Micheau O. Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion. Cell Death Dis. 2015;6:e1633 pubmed publisher
  174. Lin L, Sabnis A, Chan E, Olivas V, Cade L, Pazarentzos E, et al. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nat Genet. 2015;47:250-6 pubmed publisher
  175. Lu K, Fang X, Feng L, Jiang Y, Zhou X, Liu X, et al. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Cancer Lett. 2015;359:250-8 pubmed publisher
  176. Suo H, Song J, Zhou Y, Liu Z, Yi R, Zhu K, et al. Induction of apoptosis in HCT-116 colon cancer cells by polysaccharide of Larimichthys crocea swim bladder. Oncol Lett. 2015;9:972-978 pubmed
  177. Xiao Y, Ma C, Yi J, Wu S, Luo G, Xu X, et al. Suppressed autophagy flux in skeletal muscle of an amyotrophic lateral sclerosis mouse model during disease progression. Physiol Rep. 2015;3: pubmed publisher
  178. Valianou M, Cox A, Pichette B, Hartley S, Paladhi U, Astrinidis A. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy. Cell Cycle. 2015;14:399-407 pubmed publisher
  179. Machado Neto J, Lazarini M, Favaro P, de Melo Campos P, Scopim Ribeiro R, Franchi Junior G, et al. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. Biochim Biophys Acta. 2015;1853:583-93 pubmed publisher
  180. Gomez Bougie P, Halliez M, Maïga S, Godon C, Kervoëlen C, Pellat Deceunynck C, et al. Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups. Cancer Biol Ther. 2015;16:60-5 pubmed publisher
  181. Huang C, Sheng S, Li R, Sun X, Liu J, Huang G. Lactate promotes resistance to glucose starvation via upregulation of Bcl-2 mediated by mTOR activation. Oncol Rep. 2015;33:875-84 pubmed publisher
  182. Bernusso V, Machado Neto J, Pericole F, Vieira K, Duarte A, Traina F, et al. Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells. Biochim Biophys Acta. 2015;1853:388-95 pubmed publisher
  183. Tao W, Moore R, Smith E, Xu X. Hormonal induction and roles of Disabled-2 in lactation and involution. PLoS ONE. 2014;9:e110737 pubmed publisher
  184. Nie C, Luo Y, Zhao X, Luo N, Tong A, Liu X, et al. Caspase-9 mediates Puma activation in UCN-01-induced apoptosis. Cell Death Dis. 2014;5:e1495 pubmed publisher
  185. Bing L, Wu J, Zhang J, Chen Y, Hong Z, Zu H. DHT inhibits the Aβ25-35-induced apoptosis by regulation of seladin-1, survivin, XIAP, bax, and bcl-xl expression through a rapid PI3-K/Akt signaling in C6 glial cell lines. Neurochem Res. 2015;40:41-8 pubmed publisher
  186. Vega Naredo I, Cunha Oliveira T, Serafim T, Sardao V, Oliveira P. Analysis of pro-apoptotic protein trafficking to and from mitochondria. Methods Mol Biol. 2015;1241:163-80 pubmed publisher
  187. Zheng R, Hu W, Sui C, Ma N, Jiang Y. Effects of doxorubicin and gemcitabine on the induction of apoptosis in breast cancer cells. Oncol Rep. 2014;32:2719-25 pubmed publisher
  188. Gibot L, Chabaud S, Bouhout S, Bolduc S, Auger F, Moulin V. Anticancer properties of chitosan on human melanoma are cell line dependent. Int J Biol Macromol. 2015;72:370-9 pubmed publisher
  189. Kivisakk P, Francois K, Mbianda J, Gandhi R, Weiner H, Khoury S. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. PLoS ONE. 2014;9:e103716 pubmed publisher
  190. Shibeeb O, Wood J, Casson R, Chidlow G. Effects of a conventional photocoagulator and a 3-ns pulse laser on preconditioning responses and retinal ganglion cell survival after optic nerve crush. Exp Eye Res. 2014;127:77-90 pubmed publisher
  191. Li C, Chen J, Lu B, Shi Z, Wang H, Zhang B, et al. Molecular switch role of Akt in Polygonatum odoratum lectin-induced apoptosis and autophagy in human non-small cell lung cancer A549 cells. PLoS ONE. 2014;9:e101526 pubmed publisher
  192. Chondrogiannis G, Kastamoulas M, Kanavaros P, Vartholomatos G, Bai M, Baltogiannis D, et al. Cytokine effects on cell viability and death of prostate carcinoma cells. Biomed Res Int. 2014;2014:536049 pubmed publisher
  193. Rizvi S, Mertens J, Bronk S, Hirsova P, Dai H, Roberts L, et al. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J Biol Chem. 2014;289:22835-49 pubmed publisher
  194. Bai L, Chen J, McEachern D, Liu L, Zhou H, Aguilar A, et al. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo. PLoS ONE. 2014;9:e99404 pubmed publisher
  195. Klaus C, Kaemmerer E, Reinartz A, Schneider U, Plum P, Jeon M, et al. TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas. Cell Tissue Res. 2014;357:267-78 pubmed publisher
  196. Nakajima W, Hicks M, Tanaka N, Krystal G, Harada H. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer. Cell Death Dis. 2014;5:e1052 pubmed publisher
  197. Furuya N, Ikeda S, Sato S, Soma S, Ezaki J, Oliva Trejo J, et al. PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation. Autophagy. 2014;10:631-41 pubmed publisher
  198. Redmond E, Liu W, Hamm K, Hatch E, Cahill P, Morrow D. Perivascular delivery of Notch 1 siRNA inhibits injury-induced arterial remodeling. PLoS ONE. 2014;9:e84122 pubmed publisher
  199. Tao L, Zhou X, Shen C, Liang C, Liu B, Tao Y, et al. Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways. Mol Med Rep. 2014;9:345-9 pubmed publisher
  200. Geissler A, Haun F, Frank D, Wieland K, Simon M, Idzko M, et al. Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK. Cell Death Differ. 2013;20:1317-29 pubmed publisher
  201. Zhang J, Kundu M, Ney P. Mitophagy in mammalian cells: the reticulocyte model. Methods Enzymol. 2009;452:227-45 pubmed publisher